New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
Vicodin CR (hydrocodone bitartrate and acetaminophen) Extended Release Tablets Twice-daily Regimen Significantly Lowered Chronic Low Back Pain Intensity with 12-hour Dosing Compared to Placebo TAMPA, May 8 (HSMN NewsFeed) -- New Phase III study data s... BiopharmaceuticalsAbbott, hydrocodone, acetaminophen, Vicodin CR (Source: HSMN NewsFeed)

Patients Fret over Proposed Tylenol Limits
Potential Government Crackdown on Acetaminophen Would Lower Tylenol Dose, Ban Vicodin, Percocet (Source: Health News: CBSNews.com)